Authorized purpose: Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.
Clinical role
Supports standard diagnostic ultrasound acquisition and review. V8.1 adds Left Atrial Appendage Analysis for user-specified dimensions and shape modeling, strain-ratio measurement, Mecha4D Ultra Wideview support, stored contrast-exam review, and specified endoscopic ultrasound imaging on the Aplio i800/E3.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: When EUS transducer GF-UCT180 is connected, Aplio i800 Model TUS-AI800/E3 provides image information for diagnosis of the upper gastrointestinal tract and surrounding organs.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Ultrasound images and cine data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; the added endoscopic workflow uses the GF-UCT180 transducer on the Aplio i800/E3.
Who uses it?Intended users: Physicians or other legally qualified persons who have received appropriate training.
What does the software produce?Output: Diagnostic ultrasound images and measurements plus, where configured, left-atrial-appendage dimensions and shape models, strain ratios, wide-view Mecha4D images, stored contrast-exam displays, and upper-gastrointestinal endoscopic ultrasound images for qualified-user review.
What is its most important limitation?Key limitation: When EUS transducer GF-UCT180 is connected, Aplio i800 Model TUS-AI800/E3 provides image information for diagnosis of the upper gastrointestinal tract and surrounding organs.
Clinical takeaway. Clinical role: Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.
Evidence takeaway. Evidence from the reviewed source record: FDA-reviewed support combines manufacturer feature verification with a 10-case, single-cardiologist evaluation of Left Atrial Appendage Analysis. The summary does not report quantitative effect sizes, multisite testing, or patient outcomes.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
Supports standard diagnostic ultrasound acquisition and review. V8.1 adds Left Atrial Appendage Analysis for user-specified dimensions and shape modeling, strain-ratio measurement, Mecha4D Ultra Wideview support, stored contrast-exam review, and specified endoscopic ultrasound imaging on the Aplio i800/E3.
Ultrasound images and cine data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; the added endoscopic workflow uses the GF-UCT180 transducer on the Aplio i800/E3.
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
When EUS transducer GF-UCT180 is connected, Aplio i800 Model TUS-AI800/E3 provides image information for diagnosis of the upper gastrointestinal tract and surrounding organs.
Exact FDA submission
Checked 2026-09-19
The current value adds unreported validation and outcome limitations; this replacement preserves the exact configuration boundary stated by FDA.
FDA-reviewed support combines manufacturer feature verification with a 10-case, single-cardiologist evaluation of Left Atrial Appendage Analysis. The summary does not report quantitative effect sizes, multisite testing, or patient outcomes.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA-reviewed support combines manufacturer feature verification with a 10-case, single-cardiologist evaluation of Left Atrial Appendage Analysis. The summary does not report quantitative effect sizes, multisite testing, or patient outcomes.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K233195 Left Atrial Appendage Analysis clinical evaluation
DesignManufacturer-sponsored evaluation by one cardiologist comparing the feature with the existing manual workflow
PopulationTen in-vivo left-atrial-appendage cine datasets; patient characteristics and acquisition sites were not reported
Scopeexact submission
Tested versionLeft Atrial Appendage Analysis on Aplio i900, i800, and i700 software V8.1
Samplen=10
IndependenceSponsor or vendor study
K233195
The evaluation confirmed workflow improvement and measurement usefulness for LAA-occlusion planning, but the summary provides no effect sizes, reader variability, or patient outcomes.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Ultrasound images and cine data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; the added endoscopic workflow uses the GF-UCT180 transducer on the Aplio i800/E3.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering V8.1.
Scope: Exact product version. Confirm the installed IHE statement, DICOM services, endoscopic-video workflow, network routing, and downstream object support.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: On-premises mobile Aplio i900, i800, or i700 ultrasound console running software V8.1; the added endoscopic ultrasound workflow requires the Aplio i800/E3 and GF-UCT180 transducer.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Diagnostic ultrasound images and measurements plus, where configured, left-atrial-appendage dimensions and shape models, strain ratios, wide-view Mecha4D images, stored contrast-exam displays, and upper-gastrointestinal endoscopic ultrasound images for qualified-user review.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
On-premises mobile Aplio i900, i800, or i700 ultrasound console running software V8.1; the added endoscopic ultrasound workflow requires the Aplio i800/E3 and GF-UCT180 transducer.
The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering V8.1.
Exact product version
Checked 2026-09-02
Confirm the installed IHE statement, DICOM services, endoscopic-video workflow, network routing, and downstream object support.
Canon Medical's cybersecurity page states that Canon imaging systems follow a software development life cycle governed by the NIST 800-53 Risk Management Framework adhering to Defense Health Agency certification requirements; FIPS 140-2 certified cipher standards; deny-all firewall configuration and near-real-time SIEM syslog export as premium offerings; a dedicated cybersecurity risk management team for threat intelligence monitoring, advisories and incident response; and published OS and third-party update policies. Vendor statement; no certification or test report was read.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: the page is on us.medical.canon, Canon Medical's own site (Canon Medical Systems USA), and describes Canon Medical imaging devices generally; the FDA applicant is Canon Medical Systems Corporation, named in the corporate name-change press release on the same domain. Regional page with general device claims; exact-release scope is not established.
The GF-UCT180 transducer is integrated exclusively with the Aplio i800 TUS-AI800/E3 configuration for imaging the upper gastrointestinal tract and surrounding organs.
exact submission · checked 2026-09-02
Verify the exact console variant, transducer, endoscope compatibility, reprocessing workflow, accessories, and staff training.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
The exact device name, classification, and indications identify a diagnostic ultrasound system; the current dossier has no modality value. Controlled directory display reconciled from exact FDA wording: Diagnostic ultrasound. -> Ultrasound.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
22Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda device recall, vendor interoperability, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission
No public price or quote for the exact K233195 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Canon Aplio reimbursement CPT Medicare"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.
Ge Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.
Ge Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.